Pandemic H1N1 (Swine) Influenza Vaccine Uptake amongst Patient Groups in Primary Care in England 2009/10

This report describes and reports the results of the survey on the uptake of H1N1 vaccine amongst the targeted groups up to 31 March 2010 in England. Early provisional data on H1N1 vaccinations were published within reports issued by the Chief Medical Officer (CMO) for England during the pandemic and may differ from final data published in this report. The H1N1 vaccination programme is continuing into the 2010/11 seasonal influenza vaccination programme. H1N1 vaccine uptake data (up to 31 August 2010) will be reported in the autumn 87.4% (7333/8392) of GP practices in England provided data on H1N1 vaccinations administered up to 31 March 2010. The overall national vaccine uptake in clinical risk groups (all ages, including pregnant women) was 37.6%. The main results by priority group were as follows: National vaccine uptake in patients aged under 65 years in clinical risk groups (including pregnant women) was 35.4% Vaccine uptake by SHA ranged from 27.3% to 39.6% The lowest PCT uptake was 18.2%, whilst the highest was 44.7% 54.5% of PCTs (83/152) achieved a vaccine uptake rate of 35.0% or more The lowest uptake by age band was 20.8% in those aged 16 years to under 25 years, and the highest was 48.2% in those aged 60 years to under 65 years in a clinical risk group Uptake by clinical risk group ranged from 32.4% among patients with chronic degenerative neurological disease to 50.9% among those with diabetes (on medication) National vaccine uptake in those aged 65 years and over in clinical risk groups was 40.4% Vaccine uptake by SHA ranged from 35.7% to 46.6% The lowest PCT uptake was 21.6 % and the highest was 58.9 % 48.7% of PCTs (74/152) achieved a vaccine uptake rate of 40.0% or over National vaccine uptake in pregnant women was 14.9% Vaccine uptake by SHA ranged from 11.8% to 18.2% The lowest PCT uptake was 2.1%, whilst the highest was 24.7% 55.9% of PCTs (85/152) achieved a vaccine uptake rate of 14.0% All data on H1N1 vaccine uptake by pregnant women are likely to be less precise than data reported on other patient groups for reasons explained later in the report. Vaccine uptake in healthy children aged over six months to under five years was 23.6% Vaccine uptake by SHA ranged from 14.7% to 29.7% The lowest PCT uptake was 8.5% and the highest was 38.5% 64.5% of PCTs (98/152) achieved an uptake of more than 20%